Notch Science Marketing’s Post

📢 Attention Rare Disease Therapeutic Developers: Are you aware of the critical advantages the EMA Orphan Drug Designation offers to innovators like yourself? Pace® is excited to introduce our comprehensive whitepaper that explores the essentials of obtaining EMA ODD, a designation pivotal for those dedicated to addressing unmet medical needs in rare disease treatment. 🔍 Highlights of the Whitepaper: • Understanding EMA ODD: Learn what it is and why it's crucial for rare disease therapies. • Incentives Explained: Gain detailed insights into the financial and regulatory incentives provided under the ODD. • Application Mastery: Receive step-by-step guidance to streamline your application process and ensure success. 👉 Secure Your Guide to Success here: https://ow.ly/GXQ850S10Kv Thank you for writing such a valuable resource Clara Bechtold, PharmD, Paula Garcia Calavia, and Isaiah Manoogian. #ODD #OrphanDrugDesignation #EMA #OrphanDrug #RareDisease #Biotechnology #Biopharmaceutical #Pharmaceutical #DrugDevelopment #LifeSciences

Discover the thriving biotech landscape in the Middle East and unlock incredible opportunities! Join this unmissable session to gain valuable insights and stay ahead in this dynamic market.

🌟 Session Highlights: Advances in Drug Discovery and Development 🌟 We are thrilled to announce one of the key sessions at the upcoming Global Summit on Pharmaceutical Innovations & Drug Development (GSPIDD): ✨ Advances in Drug Discovery and Development This session will bring together leading scientists, researchers, and industry experts to discuss ground breaking innovations and challenges in the field. Key topics include: 🔹High-Throughput Screening Techniques 🔹Medicinal Chemistry for Drug Design 🔹Biomarker Identification for Drug Development 🔹Preclinical Models in Drug Discovery 🔹Target-Based and Phenotypic Screening Join us as we explore the future of pharmaceutical innovation and its impact on global healthcare! 🌍 📅 March 20-21, 2025 📍London, UK (Hybrid event) Don’t miss this opportunity to gain insights, network with global experts, and stay ahead in the evolving landscape of drug development. 👉 Register now: https://lnkd.in/gM9Xxj5F #PharmaceuticalInnovation #DrugDiscovery #DrugDevelopment #GSPIDD #GlobalConference #wavejo

The Pharmaceutical Post is excited to unveil its latest edition, featuring a fresh new design to kick off the new year!   This edition delivers comprehensive insights into the latest trends and innovations shaping the pharmaceutical industry. From groundbreaking research to emerging market opportunities, it’s packed with content you don’t want to miss:   #Ecodesign driving sustainable pharmaceutical solutions Advanced therapies revolutionizing patient #care Next-generation devices addressing #diabetes and obesity   Discover in-depth analyses and expert perspectives on these transformative trends. Access the full publication here: https://bit.ly/4af2ByY   #ThePharmaceuticalPost #DigitalEdition #Innovation #PharmaNews #Pharma #PharmaIndustry

Kickstart 2025 by partnering with Smithers Pharmaceutical Development Services As the new year begins, we know you are focused on 2025 annual goals, executing strategies to achieve them, and anticipating potential challenges to reach success. At Smithers Pharmaceutical Development Services, we understand the complexities you face and are committed to being your trusted partner throughout your large molecule drug development journey. How Smithers PDS can support your success in 2025? ·      Precision Bioanalytical Services: Expert analysis of peptides, proteins, monoclonal antibodies, and other large molecules ·      Advanced Analytical Techniques: Cutting-edge methods designed to deliver accuracy, compliance, and confidence in your results ·      Tailored Solutions for Your Needs: Custom strategies to address your specific challenges and meet regulatory expectations Your breakthroughs have the potential to change lives, and Smithers Pharmaceutical Development Services is here to help you navigate the journey with expertise and reliability.   Let’s work together to make 2025 a year of meaningful progress and achievement. Ready to tackle your goals? Contact us at infopds@smithers.com to connect and learn more about how we can support your research and development needs   #BioanalyticalServices #LargeMolecules #PharmaceuticalDevelopment #DrugDevelopment #SmithersPharmaceuticalDevelopmentServices #Welcome2025

𝐖𝐞𝐥𝐜𝐨𝐦𝐞 𝐭𝐨 𝐨𝐮𝐫 𝐞𝐱𝐜𝐥𝐮𝐬𝐢𝐯𝐞 𝐩𝐚𝐧𝐞𝐥 𝐝𝐢𝐬𝐜𝐮𝐬𝐬𝐢𝐨𝐧 𝐨𝐧 "𝐁𝐢𝐨𝐩𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥𝐬 𝐚𝐧𝐝 𝐁𝐢𝐨𝐬𝐢𝐦𝐢𝐥𝐚𝐫𝐬: 𝐌𝐚𝐫𝐤𝐞𝐭 𝐓𝐫𝐞𝐧𝐝𝐬 𝐚𝐧𝐝 𝐅𝐮𝐭𝐮𝐫𝐞 𝐏𝐫𝐨𝐬𝐩𝐞𝐜𝐭𝐬." Our esteemed panelists, Barbara Hendrickson, Gillian Woollett, and Christopher Conway, will delve into regulatory strategies, market dynamics, and innovative trends shaping the biopharmaceutical landscape. Gain invaluable insights into the evolving world of #biopharmaceuticals and #biosimilars, and discover what the future holds for the pharmaceutical industry. 𝐉𝐨𝐢𝐧 𝐮𝐬 𝐢𝐧 𝐞𝐱𝐩𝐥𝐨𝐫𝐢𝐧𝐠 𝐠𝐫𝐨𝐮𝐧𝐝𝐛𝐫𝐞𝐚𝐤𝐢𝐧𝐠 𝐭𝐫𝐞𝐧𝐝𝐬 𝐚𝐧𝐝 𝐬𝐭𝐫𝐚𝐭𝐞𝐠𝐢𝐞𝐬 𝐭𝐡𝐚𝐭 𝐩𝐫𝐨𝐦𝐢𝐬𝐞 𝐭𝐨 𝐭𝐫𝐚𝐧𝐬𝐟𝐨𝐫𝐦 𝐡𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞. 👉 https://lnkd.in/gJdi4krZ 🔗 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐭𝐡𝐞 𝐞-𝐛𝐨𝐨𝐤 𝐧𝐨𝐰: https://lnkd.in/gv7R4SPi #Biopharmaceuticals #Biosimilars #PharmaTrends #HealthcareInnovation #RegulatoryAffairs #MarketDynamics #PharmaceuticalIndustry #FutureOfPharma #PanelDiscussion #HealthcareRevolution #PharmaLeaders #InnovationInPharma #Biotech #PharmaFuture

Carl Baker, our Vice President Business Unit Drug Substance at CARBOGEN AMCIS, has been featured in the Winter 2024 edition of Innovations in Pharmaceutical Technology (IPT)! 📖 In his article, “Powering Pharma Innovation: Building a Workforce for the Future” (pages 14–17), Carl shares valuable insights on key strategies for leadership and talent development in the competitive pharmaceutical CDMO sector. 💡 Highlights include: - Fostering continuous learning to adapt and excel. - Tailoring training programs to support individual and team growth. - Promoting mentorship to inspire innovation and collaboration. These strategies reflect the forward-thinking culture we champion at CARBOGEN AMCIS. 🧠🤝 🔗 Read the full article here: https://lnkd.in/d5YczDym A big thank you to Innovations in Pharmaceutical Technology (IPT) for providing this platform to share our vision and engage with the pharmaceutical community. We’d love to hear your thoughts—let us know what resonates with you! 👇 (Innovations in Pharmaceutical Technology, December 2024, pages 14-17. © Samedan Ltd)

🌟 The European Pharma Outsourcing Summit is where 120+ pharma leaders come together to build lasting connections, share knowledge, and drive innovation in the pharmaceutical industry. This event is designed to help executives tackle industry challenges, discover solutions, and collaborate with peers from top companies like Bayer, Bristol Myers Squibb, AbbVie, Gilead Sciences, Roche, UCB, Moderna, Pfizer, Ipsen, and more. We're excited about the opportunities this year's summit will bring and its impact on advancing the pharma sector. 👉 Learn more about our mission and how to get involved: https://hubs.ly/Q02_KNqN0 #PharmaInnovation #GenerisEPOS #Networking #PharmaceuticalLeadership

Best selling pharma medicines: 📌 Eli Lilly: Mounjaro, Trulicity, Zepbound 📌 Bristol-Myers Squibb: Eliquis, Revlimid, Opdivo 📌 Novartis: Entresto, Cosentyx, Kesimpta 📌 Roche: Ocrevus, Hemlibra, Vabysmo 📌 AstraZeneca: Tagrisso, Imfinzi, Farxiga 📌 AbbVie: Skyrizi, Humira, Rinvoq 📌 Johnson & Johnson: Darzalex, Erleada, Stelara 📌 Sanofi: Dupixent, Flublok, Quadracel 📌 Merck: Keytruda, Gardasil 9, Lynparza 📌 Pfizer: Paxlovid, Eliquis, Prevnar 20 This data underscores the significant influence of leading companies such as Johnson & Johnson, Novartis, Roche, Pfizer, and Sanofi in driving advancements in healthcare and treatment innovation. The global pharmaceutical market continues to expand, highlighting rapid developments and opportunities in drug delivery systems, precision medicine, and biopharmaceutical technologies. Source: Statpedia #pharmaceuticals #biopharma #biotech #pharma

"Our system is outdated and not patient-centered. Modern healthcare systems place the patient's journey through the system at the center—from prevention and diagnosis to monitoring the course and outcomes of treatment. To achieve this, we need to significantly improve data collection and utilization, enable patients to access innovative drugs and treatment methods, and ensure educated and motivated staff in healthcare institutions," emphasized Sani Pogorilić, Executive Director of Inovativna farmaceutska inicijativa / Innovative Pharmaceutical Initiative, which gathers innovative pharmaceutical companies in the Croatian market, during the panel discussion "Action Plan for Health 2030: How to turn a shared vision into reality?"